Synthetic Biology Technologies and Products


MAGIGENE has been authorized by Sun Yat-sen University for the use of patent Preparation and Use of Inducible Mutant Protein Based on Activation of Inducible Cytidine Deaminase. This system allows us to mutate the CDR sequence of VHH. By continuously mutating the yeast, we generate a diverse VHH library from which we can extract antigen-specific VHH using the yeast surface display method. Compared to traditional VHH screening from immune libraries of camelidae, the mutagenesis screening VHH system offers significant advantages in terms of cost, iteration, parallelism, and time-saving.  Findrop Biosafety Technology (Guangzhou), a wholly-owned subsidiary of MAGIGENE, now implements this patented technology for nanobody screening, nanobody product development, and related technical services

Magi Gene

Magi Kefu

Contact Us

Address: Floor 13, Block B, Building 7, Phase 3, International Innovation Valley, Shenzhen

Address: 28th Floor, Building A, Guanzhou Life Science Center, Guangzhou International BioIsland

Address: 4F, Building 3, Phase 2, Guangzhou International Biological Island

Copyright©2023 Guangdong Magigene Biotechnology Co., Ltd.


图片ALT信息: Guangdong Meige Gene Technology Co., Ltd.


Sorry, the current column has no content for the time being.!

You can view other columns or returnHome Page

V1.3.1 SVG图标库请自行添加图标,用div包起来,并命名使用